⌘+K

Pulse Explore Clubs Researchers Journals

Home Clubs Explore

June 7, 2024Japanese Journal of Clinical OncologyOpen Access

Real-world treatment trends for patients with advanced prostate cancer and renal cell carcinoma and their cost—a survey in Japan

Takahiro Osawa Keita Sasaki Ryunosuke Machida Takashi Matsumoto Yoshiyuki Matsui Hiroshi Kitamura Hiroyuki Nishiyama

View Full Paper

Ask AI

Bookmark

Share

Abstract

Advanced (Stage IV) prostate and renal cancer have poor prognosis, and several therapies have been developed, but many are very costly. This study investigated drug regimens used in patients with untreated Stage IV prostate cancer and renal cell carcinoma and calculated the monthly cost of each.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Osawa et al. (2024) studied this question.

synapsesocial.com/papers/68e65999b6db6435875e8dfa https://doi.org/10.1093/jjco/hyae045

View Full Paper

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1High-cost treatments for advanced lung cancer in Japan (Lung Cancer Study Group of the Japan Clinical Oncology Group)2024 · 10 citations
2Current status of the cost burden of first-line systemic treatment for patients with advanced hepatocellular carcinoma in Japan, 2021–222024 · 6 citations
3A real-world survey on expensive drugs used as first-line chemotherapy in patients with HER2-negative unresectable advanced/recurrent gastric cancer in the stomach cancer study group of the Japan clinical oncology group2024 · 4 citations
4Comparative Effectiveness of Management Strategies for Stage IV Prostate Cancer: A Narrative Review2025
5Frequency of use and cost in Japan of first-line palliative chemotherapies for recurrent or metastatic squamous cell carcinoma of the head and neck2024 · 4 citations